Fentanyl Addiction

What is fentanyl?

Fentanyl is a fully synthetic opioid originally developed for medical pain management, particularly for cancer patients with severe, chronic pain that other opioids could not adequately control. It belongs to the same drug class as morphine, heroin, and oxycodone, but it is far more concentrated. A therapeutic dose is measured in micrograms, not milligrams. In clinical settings, fentanyl patches, lozenges, and injections are closely monitored because the therapeutic window is so narrow.

The illicit fentanyl that drives today's overdose crisis is almost entirely manufactured outside of pharmaceutical channels. It is imported primarily as a powder or pressed into counterfeit pills designed to mimic oxycodone (M30s), Xanax, or other commonly misused medications. It is also routinely mixed into heroin, cocaine, and methamphetamine supplies, often without the buyer's knowledge or consent. Because fentanyl is so potent, an amount equivalent to a few grains of salt can be lethal.

Fentanyl analogs, including carfentanil (estimated at 100 times the potency of fentanyl itself), nitazenes, and other novel synthetic opioids, are increasingly appearing in the drug supply as well. The landscape shifts faster than testing can keep up.

How fentanyl addiction develops

Fentanyl works by binding to the mu-opioid receptors concentrated in the brain, spinal cord, and gut. In the brain, this produces rapid and intense analgesia, sedation, and euphoria. The reward signal is powerful. The brain's dopamine system responds to fentanyl with a surge that far exceeds what natural rewards produce, and it adapts quickly.

With repeated exposure, the brain down-regulates its own opioid receptors and reduces its natural production of endorphins. The person needs the drug just to feel normal. Tolerance builds fast, meaning more fentanyl is needed to produce the same effect, and stopping produces withdrawal symptoms that feel like a severe flu combined with intense psychological distress. That cycle, use to feel okay, more use to chase the original effect, withdrawal driving continued use, is the engine of opioid use disorder.

Fentanyl use disorder meets the clinical criteria for Opioid Use Disorder (OUD) as defined in the DSM-5. It is characterized by a problematic pattern of opioid use leading to significant impairment, including failed attempts to control use, tolerance, withdrawal, and continued use despite serious consequences. The severity is rated on a spectrum from mild (two to three criteria) to moderate (four to five criteria) to severe (six or more criteria). Fentanyl's potency means it can push someone into severe OUD faster than other opioids.

Physical and psychological warning signs

Fentanyl affects virtually every system in the body. The signs of active use and emerging dependence include both physical changes that others may notice and internal experiences only the person using may describe.

• Extreme drowsiness, sedation, or 'nodding off' mid-conversation
• Pinpoint (very small) pupils regardless of lighting conditions
• Slowed, shallow, or irregular breathing -- the most dangerous sign
• Pale, bluish, or grayish skin tone, particularly around the lips (a sign of oxygen deprivation)
• Confusion, disorientation, or an inability to stay alert
• Rapidly escalating tolerance -- needing more, more frequently
• Withdrawal symptoms (nausea, muscle aches, sweating, anxiety, insomnia) when the drug wears off
• Obsessive focus on obtaining the next dose, even at the expense of relationships and responsibilities
• Possession of naloxone or fentanyl test strips as signs of high-risk, high-awareness use
• Isolation, financial problems, and secrecy around drug-related activities

The overdose risk: why fentanyl is different

Opioid overdose occurs when the drug suppresses the brainstem to the point where the drive to breathe slows and then stops. Every opioid can do this, but fentanyl's potency compresses the timeline. A person can go from conscious to unconscious to respiratory arrest in minutes.

The contamination problem multiplies the risk. Someone buying a street pill or powder has no reliable way to know whether it contains fentanyl, how much, or how evenly it is distributed (a phenomenon called 'hot spots' where one part of a pill contains far more fentanyl than another). This means even experienced users who believe they know their dose are taking an unpredictable risk with every use.

Naloxone (brand name Narcan) reverses opioid overdose by blocking opioid receptors. It works on fentanyl, but the high potency and rapid onset sometimes require multiple doses. Naloxone is available without a prescription at pharmacies in New Jersey, and it is available at no cost through various state programs. Every person who uses opioids or lives with someone who does should have naloxone on hand and know how to use it.

New Jersey has seen significant overdose mortality in Monmouth County and across the Shore region. The pattern in our area reflects the national picture: contaminated supply, isolation, and the speed at which fentanyl acts before anyone can respond.

Fentanyl withdrawal: what to expect

Withdrawal from fentanyl and other opioids follows a predictable pattern, though the intensity varies depending on how long a person has been using, how much, and their individual physiology. For short-acting opioids like heroin and illicit fentanyl, withdrawal typically begins within 8 to 24 hours of the last dose.

Early symptoms include anxiety, agitation, yawning, runny nose, and muscle cramps. By 24 to 72 hours, the peak hits: severe muscle aches and cramps, vomiting, diarrhea, insomnia, rapid heart rate, elevated blood pressure, chills alternating with sweating, and overwhelming cravings. The acute phase usually subsides within five to seven days, though protracted withdrawal symptoms, including dysphoria, sleep disturbance, and diminished ability to feel pleasure (anhedonia), can persist for weeks to months.

Fentanyl withdrawal is not typically life-threatening for otherwise healthy adults, unlike alcohol and benzodiazepine withdrawal. But it is extremely uncomfortable and the relapse risk during withdrawal is very high. Archangel coordinates with medical detox partners for clients who need supervised withdrawal management before stepping into our outpatient programs. We do not provide on-site inpatient detox, but we guide every client through the process of finding safe, medically supervised detox and then transitioning directly into structured outpatient care.

Medication-assisted treatment (MAT) for fentanyl

Medication-assisted treatment is the evidence-based standard of care for opioid use disorder, and it saves lives. Three FDA-approved medications are used:

Buprenorphine (Suboxone, Sublocade): A partial opioid agonist that binds to opioid receptors strongly enough to eliminate withdrawal and cravings, but with a ceiling effect that dramatically reduces overdose risk. Suboxone is a sublingual film combining buprenorphine with naloxone to deter misuse. Sublocade is a monthly injectable buprenorphine formulation that removes the daily dosing challenge. Buprenorphine can be prescribed by a licensed clinician in an outpatient office setting, which makes it highly accessible. Archangel works with prescribers to integrate buprenorphine into our outpatient programs.

Methadone: A full opioid agonist that eliminates withdrawal and cravings but requires daily dispensing through a federally licensed opioid treatment program (OTP). More intensive but highly effective for people with severe, long-standing OUD.

Naltrexone (Vivitrol): An opioid antagonist that blocks opioid receptors so that using fentanyl or any opioid produces no effect. Available as a monthly injection, it works best after full detoxification and is a good option for highly motivated clients who prefer a non-opioid medication. It cannot be started until the person is fully free of opioids, typically 7 to 14 days, because it will precipitate immediate, severe withdrawal.

MAT is not a crutch or a replacement addiction. Research consistently shows that people on MAT have lower rates of illicit drug use, fewer overdose deaths, better treatment retention, and improved social functioning compared to those in abstinence-only programs. The goal is a stable, functioning life. Medication supports that goal.

Co-occurring mental health and fentanyl

The relationship between opioid use and mental health is bidirectional and complex. Depression, anxiety, trauma, and PTSD are the most common co-occurring conditions among people with OUD. Some people begin using opioids to manage emotional pain long before they recognize it as self-medication. Others develop mood disorders as a consequence of chronic opioid use and the life disruption that follows.

Effective treatment addresses both simultaneously. Treating the addiction while ignoring the underlying depression or trauma creates a revolving door. Treating the mental health condition while minimizing the addiction does the same. Archangel's clinical team conducts dual-diagnosis assessments and builds integrated treatment plans that account for the full picture.

Trauma history is particularly common among people with OUD. Many clients have histories of adverse childhood experiences, domestic violence, sexual assault, or grief that drive the original pull toward numbing. Trauma-informed care is not optional in this population; it is the standard of quality care.

The Archangel Centers outpatient treatment pathway

Archangel Behavioral Health in Tinton Falls, NJ offers licensed outpatient treatment for fentanyl use disorder. We serve Monmouth County and the broader Jersey Shore area, with clients coming from Red Bank, Asbury Park, Long Branch, Neptune, and surrounding communities.

Our levels of care follow the ASAM (American Society of Addiction Medicine) continuum and step down as the client stabilizes:

Partial Hospitalization Program (PHP): The most intensive outpatient level, typically five days a week for several hours each day. Structured programming including group therapy, individual therapy, medication management, and psychoeducation. Appropriate for clients who have completed detox and need a high level of support before stepping down.

Intensive Outpatient Program (IOP): Three days a week, three or more hours per session. The IOP is the backbone of most recovery plans for opioid use disorder, providing enough structure and accountability to support early recovery while allowing clients to maintain work, family, and daily life.

Standard Outpatient (OP): Weekly or twice-weekly individual and group sessions for clients in stable recovery who need ongoing support and accountability.

Every client at Archangel works with a licensed clinician to build an individualized treatment plan. MAT integration, trauma-informed care, family support, and relapse prevention are built into every level of care.

What recovery looks like

Recovery from fentanyl addiction is possible. People with severe, chronic OUD who engage consistently with MAT and behavioral therapy achieve sustained recovery. The early months are the hardest: cravings are strongest, the brain is still recalibrating, and old environments and relationships pose real relapse risk. A structured outpatient program provides the container and accountability that makes those months survivable.

Over time, recovery expands. People return to work, rebuild relationships, rediscover who they were before the addiction took hold. The founder-led story at the heart of Archangel is not an exception to what recovery looks like. It is an example of what it can be: a full return to the life you were meant to live.

If you are searching for fentanyl treatment in Monmouth County or anywhere along the Jersey Shore, our admissions team is available around the clock. You can call, text, or submit your insurance information online to start the conversation. There is no commitment required to find out what your options are.